Home > National Drug Code (NDC) > Ceftazidime

Ceftazidime - 25021-129-99 - (ceftazidime)

Alphabetical Index


Drug Information of Ceftazidime

Product NDC: 25021-129
Proprietary Name: Ceftazidime
Non Proprietary Name: ceftazidime
Active Ingredient(s): 6    g/30mL & nbsp;   ceftazidime
Administration Route(s): INTRAVENOUS
Dosage Form(s): INJECTION, POWDER, FOR SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Ceftazidime

Product NDC: 25021-129
Labeler Name: Sagent Pharmaceuticals
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA062640
Marketing Category: ANDA
Start Marketing Date: 20080515

Package Information of Ceftazidime

Package NDC: 25021-129-99
Package Description: 6 BOTTLE in 1 CARTON (25021-129-99) > 30 mL in 1 BOTTLE

NDC Information of Ceftazidime

NDC Code 25021-129-99
Proprietary Name Ceftazidime
Package Description 6 BOTTLE in 1 CARTON (25021-129-99) > 30 mL in 1 BOTTLE
Product NDC 25021-129
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ceftazidime
Dosage Form Name INJECTION, POWDER, FOR SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 20080515
Marketing Category Name ANDA
Labeler Name Sagent Pharmaceuticals
Substance Name CEFTAZIDIME
Strength Number 6
Strength Unit g/30mL
Pharmaceutical Classes Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient]

Complete Information of Ceftazidime


General Information